An Act relative to epinephrine injectors

HD 2251 requires all health insurance plans in Massachusetts - covering Commonwealth employees, Medicaid members, private accident/sickness policies, and health maintenance organizations - to cover FDA-approved epinephrine injectors (like EpiPens) without higher out-of-pocket costs than other prescribed medications. The bill applies to weight-based dosages and mandates that insurers cannot impose stricter deductibles, copays, or coinsurance for these injectors compared to other drugs. It directly affects individuals with severe allergies who rely on epinephrine for emergencies, ensuring consistent access to life-saving medication through existing insurance coverage. The law updates multiple insurance chapters to standardize this coverage requirement across all major health plan types in the state.